In a significant move for women’s health, actress Emma Watson has made a previously undisclosed investment in Hertility, a pioneering company focused on women’s reproductive health. This investment brings the company’s total funding to over $14 million, highlighting Watson’s commitment to supporting women-led initiatives.
Championing Gender Equality and Women’s Health
Her investment in Hertility aligns perfectly with her values, emphasizing the need for improved healthcare options for women.
Dr. Helen O’Neill, CEO and co-founder of Hertility, shared that Watson was introduced to the company through one of its investors, who believed her passion for women’s rights made her an ideal partner. “Hertility was founded by women and focuses on women’s health—an area that historically hasn’t received enough attention or funding,” O’Neill stated in an interview with TechCrunch.
Innovative Solutions for Women’s Reproductive Health
Co-founded by Dr. O’Neill, ovarian biologist Dr. Natalie Getreu, and corporate lawyer Deirdre O’Neill, Hertility aims to innovate tools for researching and improving women’s reproductive health. The company offers personalized testing and services, including diagnostic testing, egg freezing, and telemedicine, addressing the unique healthcare needs of women throughout their reproductive journeys.
Addressing Healthcare Gaps in the UK
Operating in the U.K., Hertility addresses a pressing issue: over 600,000 women are currently waiting for gynecology appointments. The country’s healthcare system is facing significant wait times, pushing many to seek private medical care. A recent Deloitte study highlights a substantial gap in women’s health funding, revealing that women with jobs incur out-of-pocket health costs $15 billion higher than their male counterparts.
A Collaborative Future for Women’s Health
Emma Watson’s investment not only supports a female-founded company but also empowers women in business and health. As Hertility continues to grow, it seeks to reshape the narrative around women’s healthcare, making vital services more accessible and personalized. The collaboration between Watson and Hertility exemplifies the potential for change when advocates and innovators come together for a common cause.
Read Also: South Korea and the Philippines Forge $2 Billion Infrastructure Partnership
